Comparison of olanzapine long-acting injection and oral olanzapine: a 2-year, randomized, open-label study in outpatients with schizophrenia.

Detke, Holland C; Weiden, Peter J; Llorca, Pierre-Michel; Choukour, Moutaz; Watson, Susan B; Brunner, Elizabeth; Ascher-Svanum, Haya

Detke, Holland C; Weiden, Peter J; Llorca, Pierre-Michel; Choukour, Moutaz; Watson, Susan B; Brunner, Elizabeth; Ascher-Svanum, Haya.

Affiliation

Detke HC; From the *Lilly Research Laboratories, Indianapolis, IN; Department of Psychiatry, University of Illinois, Chicago, IL; Centre Hospitalier Universitaire, Université d'Auvergne, Clermont Ferrand, France; and §i3 Statprobe, Lexington, KY.

J Clin Psychopharmacol ; 34(4): 426-34, 2014 Aug.

Article in En | MEDLINE | ID: mdl-24781441

Subject(s)

Ambulatory Care/methods; Antipsychotic Agents/administration & dosage; Benzodiazepines/administration & dosage; Schizophrenia/diagnosis; Schizophrenia/drug therapy; Administration, Oral; Adult; Delayed-Action Preparations/administration & dosage; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Patient Satisfaction; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Benzodiazepines / Ambulatory Care Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychopharmacol Year: 2014 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google